NYSE:SYKStryker Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stryker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $177.86 -0.03 (-0.02 %) (As of 07/13/2020 04:00 PM ET) Add Compare Share Today's Range$177.14Now: $177.86▼$181.4150-Day Range$173.76MA: $188.08▼$207.0352-Week Range$124.54Now: $177.86▼$226.30Volume1.95 million shsAverage Volume2.02 million shsMarket Capitalization$66.67 billionP/E Ratio31.26Dividend Yield1.29%Beta0.84 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingStryker has received a consensus rating of Buy. The company's average rating score is 2.62, and is based on 16 buy ratings, 7 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $215.20, Stryker has a potential upside of 21.0% from its current price of $177.86.Amount of Analyst CoverageStryker has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.6 Community Rank Outperform VotesStryker has received 790 “outperform” votes. (Add your “outperform” vote.)Underperform VotesStryker has received 759 “underperform” votes. (Add your “underperform” vote.)Community SentimentStryker has received 51.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote “Outperform” if you believe SYK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldStryker has a dividend yield of 1.29%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthStryker has been increasing its dividend for 9 years.Dividend CoverageThe dividend payout ratio of Stryker is 27.85%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Stryker will have a dividend payout ratio of 26.23% next year. This indicates that Stryker will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stryker insiders have sold 59,469.38% more of their company's stock than they have bought. Specifically, they have bought $9,695.00 in company stock and sold $5,775,251.00 in company stock.Percentage Held by InsidersOnly 6.80% of the stock of Stryker is held by insiders.Percentage Held by Institutions71.24% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Stryker are expected to grow by 41.00% in the coming year, from $6.22 to $8.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stryker is 31.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Stryker is 31.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.06.Price to Earnings Growth RatioStryker has a PEG Ratio of 3.11. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStryker has a P/B Ratio of 5.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.26 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:SYK Previous Symbol CUSIP86366710 CIK310764 Webwww.strykercorp.com Phone269-389-2600Debt Debt-to-Equity Ratio0.72 Current Ratio2.58 Quick Ratio1.77Price-To-Earnings Trailing P/E Ratio31.26 Forward P/E Ratio28.59 P/E Growth3.11 Sales & Book Value Annual Sales$14.88 billion Price / Sales4.48 Cash Flow$10.47 per share Price / Cash Flow16.99 Book Value$34.23 per share Price / Book5.20Profitability EPS (Most Recent Fiscal Year)$8.26 Net Income$2.08 billion Net Margins14.47% Return on Equity24.90% Return on Assets11.10%Miscellaneous Employees40,000 Outstanding Shares374,828,000Market Cap$66.67 billion Next Earnings Date7/30/2020 (Confirmed) OptionableOptionable SYK Rates by TradingView Receive SYK News and Ratings via Email Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter. Stryker (NYSE:SYK) Frequently Asked Questions How has Stryker's stock been impacted by COVID-19 (Coronavirus)? Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SYK shares have increased by 1.3% and is now trading at $177.86. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Stryker? 26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker. When is Stryker's next earnings date? Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Stryker. How can I listen to Stryker's earnings call? Stryker will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. How were Stryker's earnings last quarter? Stryker Co. (NYSE:SYK) posted its earnings results on Thursday, April, 30th. The medical technology company reported $1.84 EPS for the quarter, topping the Zacks' consensus estimate of $1.69 by $0.15. The medical technology company had revenue of $3.59 billion for the quarter, compared to analysts' expectations of $3.45 billion. Stryker had a net margin of 14.47% and a return on equity of 24.90%. The firm's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period last year, the firm posted $1.88 EPS. View Stryker's earnings history. How often does Stryker pay dividends? What is the dividend yield for Stryker? Stryker announced a quarterly dividend on Tuesday, May 5th. Investors of record on Tuesday, June 30th will be given a dividend of $0.575 per share on Friday, July 31st. This represents a $2.30 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Monday, June 29th. View Stryker's dividend history. What price target have analysts set for SYK? 26 brokerages have issued 12-month price targets for Stryker's shares. Their forecasts range from $150.00 to $248.00. On average, they expect Stryker's share price to reach $215.20 in the next year. This suggests a possible upside of 21.0% from the stock's current price. View analysts' price targets for Stryker. Has Stryker been receiving favorable news coverage? Media headlines about SYK stock have been trending very negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stryker earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned media headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Stryker. Are investors shorting Stryker? Stryker saw a decrease in short interest in June. As of June 15th, there was short interest totaling 3,130,000 shares, a decrease of 24.0% from the May 31st total of 4,120,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the days-to-cover ratio is presently 1.3 days. Approximately 0.9% of the shares of the stock are sold short. View Stryker's Current Options Chain. Who are some of Stryker's key competitors? Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD), Steris (STE) and Masimo (MASI). View all competitors. What other stocks do shareholders of Stryker own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Medtronic (MDT), Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Visa (V), Alibaba Group (BABA), Bank of America (BAC) and NVIDIA (NVDA). Who are Stryker's key executives? Stryker's management team includes the following people: Mr. Kevin A. Lobo, Chairman & CEO (Age 54)Mr. Timothy J. Scannell, Pres & COO (Age 54)Mr. Glenn S. Boehnlein, VP & CFO (Age 57)Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57) What is Stryker's stock symbol? Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK." Who are Stryker's major shareholders? Stryker's stock is owned by many different institutional and retail investors. Top institutional investors include LGT Capital Partners LTD. (0.10%), Confluence Investment Management LLC (0.09%), Envestnet Asset Management Inc. (0.08%), Whittier Trust Co. (0.05%), Chesley Taft & Associates LLC (0.04%) and Capital Investment Services of America Inc. (0.03%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker. Which major investors are selling Stryker stock? SYK stock was sold by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, Dalton Greiner Hartman Maher & Co., Private Trust Co. NA, Addenda Capital Inc., Chesley Taft & Associates LLC, Stonebridge Capital Management Inc., Alpha Cubed Investments LLC, and Global Retirement Partners LLC. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker. Which major investors are buying Stryker stock? SYK stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Park National Corp OH, American National Bank, LGT Capital Partners LTD., Carnegie Capital Asset Management LLC, Canandaigua National Corp, Legacy Private Trust Co., and Fulton Bank N. A.. View insider buying and selling activity for Stryker. How do I buy shares of Stryker? Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Stryker's stock price today? One share of SYK stock can currently be purchased for approximately $177.86. How big of a company is Stryker? Stryker has a market capitalization of $66.67 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. What is Stryker's official website? The official website for Stryker is www.strykercorp.com. How can I contact Stryker? Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected] This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
